These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 74713)

  • 1. Long-term treatment of homozygous familial hypercholesterolaemia with 3-hydroxy-3-methylglutaric acid.
    Lupien PJ; Brun D; Moorjani S
    Lancet; 1978 Feb; 1(8058):283-4. PubMed ID: 74713
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of 3-hydroxy-3-methylglutaric acid in familial hypercholesterolaemia.
    Lupien PJ; Brun D; Moorjani S
    Lancet; 1973 Jun; 1(7814):1256. PubMed ID: 4122608
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypocholesterolemic effect of 3-hydroxy-3-methylglutaric acid.
    Beg ZH; Siddiqi M
    Experientia; 1967 May; 23(5):380. PubMed ID: 6065779
    [No Abstract]   [Full Text] [Related]  

  • 4. Homozygous hypercholesterolaemia and ezetimibe: a case report.
    Hendriksz CJ; Norbury G; Tabrah S; Taylor A; Humphries SE
    Acta Paediatr; 2004 Feb; 93(2):280-2. PubMed ID: 15046291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A factor in milk which influences cholestermia in rats.
    Nair CR; Mann GV
    Atherosclerosis; 1977 Mar; 26(3):363-7. PubMed ID: 849381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 3-hydroxy-3-methylglutaric acid on hypercholesterolemic liver.
    Beg ZH; Siddiqu M; Siddiqi RA
    Experientia; 1968 Jan; 24(1):15-6. PubMed ID: 5637601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of severe hyperlipidemia].
    Tonstad S; Leren TP; Ose L
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4241-4. PubMed ID: 9441469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
    Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term atorvastatin-ezetimibe-probucol triple therapy for homozygous familial hypercholesterolaemia from early childhood.
    Lin M; Dai H; Zhao S
    Cardiol Young; 2016 Jan; 26(1):197-201. PubMed ID: 25907359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.
    Leipold R; Raal F; Ishak J; Hovingh K; Phillips H
    Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH).
    Muntoni S; Pisciotta L; Muntoni S; Bertolini S
    J Clin Lipidol; 2015; 9(1):103-6. PubMed ID: 25670367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ distribution of 3-hydroxy-3-methylglutaric acid, a potential anticholesterolemic agent.
    Savoie LL; Lupien PJ
    Can J Physiol Pharmacol; 1975 Aug; 53(4):638-43. PubMed ID: 1175089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia.
    Sirtori CR; Pavanello C; Bertolini S
    Ann Med; 2014 Nov; 46(7):464-74. PubMed ID: 24987866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is lomitapide a life-saving drug in homozygous familial hypercholesterolemia.
    Bruckert E; Gallo A
    Eur J Prev Cardiol; 2017 Nov; 24(17):1841-1842. PubMed ID: 28952803
    [No Abstract]   [Full Text] [Related]  

  • 15. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.
    Betteridge DJ; Krone W; Reckless JP; Galton DJ
    Lancet; 1978 Dec 23-30; 2(8104-5):1342-3. PubMed ID: 82843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of children with hypercholesterolemia].
    Girardet JP
    Arch Pediatr; 2006 Jan; 13(1):104-10. PubMed ID: 16257193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous familial hypercholesterolemia: case report of a rare cause of dyslipidemia.
    Alves C; Braid Z
    Pediatr Endocrinol Diabetes Metab; 2011; 17(3):162-5. PubMed ID: 22027071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance.
    Charles Z; Pugh E; Barnett D
    Heart; 2008 May; 94(5):642-3. PubMed ID: 18411354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ezetimibe (Ezetrol)].
    Scheen AJ
    Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide.
    Roeters van Lennep J; Averna M; Alonso R
    J Clin Lipidol; 2015; 9(4):607-17. PubMed ID: 26228681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.